Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort-Reference-Cited by-同舟云学术

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort

Published:2024-03 Issue: Volume:45 Page:100715
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Bultijnck Renée^ORCID,Van Hemelrijck Mieke,Fonteyne Valérie,Livi Lorenzo,Jereczek-Fossa Barbara Alicja,Hemmatazad Hossein^ORCID,Mayinger Michael,Peulen Heike,Verbeke Luc,Ramella Sara^ORCID,Castro Pablo^ORCID,Tsoutsou Pelagia,Stellamans Karin,Shaukat Adnan,Orazem Miha,Jeene Paul^ORCID,Braam Pètra^ORCID,Verkooijen Helena,Simek Inga-Malin^ORCID,Alongi Filippo,Clementel Enrico,Fortpied Catherine,Machingura Abigirl^ORCID,Boakye Oppong Felix,Guckenberger Matthias,Ost Piet^ORCID

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018

2. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial;Phillips;JAMA Oncol,2020

3. Consolidative radiotherapy for limited metastatic non–small-cell lung cancer: a phase 2 randomized clinical trial;Iyengar;JAMA Oncol.,2018

4. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation;Guckenberger;Lancet Oncol,2020

5. Oligometastatic prostate cancer: reality or figment of imagination?;Foster;Cancer,2019